tiprankstipranks
Trending News
More News >
Mannkind Corp. (MNKD)
NASDAQ:MNKD

MannKind (MNKD) Similar Stocks

Compare
1,762 Followers

Comparison Results

Name
Price
Market Cap
P/E Ratio
Yearly Gain
Analyst Consensus
Analyst Price Target
Top Analysts' Price Target
Smart Score
Follow
MannKind
$4.58
$1.39B
50.05
10.82%
6 Buy
0 Hold
0 Sell
Strong Buy
Arrowhead Pharmaceuticals
$13.01
$1.70B
-45.29%
7 Buy
4 Hold
0 Sell
Moderate Buy
BioCryst
$7.96
$1.63B
81.74%
10 Buy
1 Hold
0 Sell
Strong Buy
Agios Pharma
$28.37
$1.60B
2.46
-10.81%
5 Buy
2 Hold
0 Sell
Moderate Buy
Beam Therapeutics
$19.13
$1.91B
-15.34%
12 Buy
3 Hold
0 Sell
Strong Buy
Kymera Therapeutics
$28.80
$1.87B
-14.03%
10 Buy
1 Hold
0 Sell
Strong Buy

Performance Comparison

Ticker
Company Name
Price
Change
% Change
MNKD
MannKind
4.61
0.42
10.02%
ARWR
Arrowhead Pharmaceuticals
13.01
-10.28
-44.14%
BCRX
BioCryst
7.96
3.75
89.07%
AGIO
Agios Pharma
28.37
-3.30
-10.42%
BEAM
Beam Therapeutics
19.87
-2.87
-12.62%
KYMR
Kymera Therapeutics
30.70
-4.51
-12.81%
Compare key indicators and discover each stock’s average analyst price target, as well as the latest recommendations by top Wall Street experts
What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis